You can find out more about Covid, if you are eligible for the Covid vaccine and how to book an appointment at NHS.UK.

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about ...

In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine project championed by two scientists who were recently tapped to serve in ...

Prof Trauer said the best protection for people, particularly those who are immunocompromised or vulnerable to Covid, is through vaccination. 'The most recent vaccines are likely to be the most ...

The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for winter. In August 2024, the U.S. Food and Drug Administration approved the updated ...

Pieter Cullis a co-founder and have shares in Acuitas Therapeutics, the company that provided the LNP enabling the Pfizer/BioNTech COVID-19 vaccine. He receives funding from CIHR. University of ...

Australians are being urged to protect themselves and their loved ones this winter amid reports a new Covid variant is on ... urged to consider a booster vaccine to protect loved ones and ...

In response to questions about whether other vaccines previously safety tested would be newly scrutinized, the department focused on its concerns around the coronavirus vaccine but did not address ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

A man who predicted Covid-19 years before it swept the globe and killed millions fears the next pandemic could already be unfolding. “But there's always a lot of randomness built into this ...

The President Donald Trump administration’s request for Novavax Inc. NVAX to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug ...